Abstract
Twenty patients with perennial nasal allergy were treated with Linovin nebulizer or nasal spray, histamine-carried human gamma globulin.1. In the group treated with Linovin nebulizer (1/3v) twice a week for 4 weeks, the clinical effect was good in 3 cases (42.9%).2. In the group treated with Linovin nasal spray (1 or 2v/w) using the device for nose drop, the clinical effect was excellent in 8 cases (61.5%) and good in 5 cases (38.5%).3. Symptomatic improvement was apparent within two weeks of nasal spray therapy, earlier than in those treated with Linovin nebulizer.4. No side effects were observed in any patients.Linovin nasal spray using the device for nose drops is useful for patients suffering from allergic rhinitis.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.